Conclusions: IGFBP-1, -2, and -7, through their consequent senescence, have a role in the progression of NAFLD and its associated fibrosis, being a plausible determinant in the progression from steatosis to NASH. Here, IGFBP1 is linked to metabolic dysfunction-associated steatohepatitis.